(4R)-4-amino-1,2-oxazolidin-3-one;(4R)-4-aminoisoxazolidin-3-one;SPBio_000008;DivK1c_000098;BSPBio_001138;Prestwick3_001089;Cycloserine (JP15/USP/INN);D00877;Seromycin (TN);MLS000758215;(R)-4-AMINO-ISOXAZOLIDIN-3-ONE;4AX;Spectrum2_000084;BPBio1_001252;AIDS-007654;SMR000058313;CAS-68-41-7;NCGC00016306-01;CAS-339-72-0;NCGC00016306-02;(4R)-4-Amino-3-isoxazolidinone;(R)-(+)-Cycloserine;(R)-4-Amino-3-isoxazolidinone;(R)-Cycloserine;3-Isoxazolidinone, 4-amino-, (4R)- (9CI);3-Isoxazolidinone, 4-amino-, (R);3-Isoxazolidinone, 4-amino-, D;Closerin;D-CS;Micoserina;Lopac0_000252;C08057;(+)-4-Amino-3-isoxazolidinone;3-Isoxazolidinone, 4-amino-, (+)- (8CI);IDI1_000098;SMP1_000167;BRN 0080798;Cicloserina [INN-Spanish];Cicloserina [Italian];Closina;Cycloserine [BAN:INN:JAN];Cycloserinum [INN-Latin];D-4-Amino-3-isossazolidone [Italian];DRG-0195;E-733-A;EINECS 200-688-4;HSDB 3218;I-1431;K-300;Miroserina;NSC 154851;Oxamicina [Italian];PA 94;Ro-1-9213;SPECTRUM1500215;AIDS-032282;AIDS032282;Cycloserine & CRL8131;Prestwick1_001089;KBio1_000098;EU-0100252;Spectrum_000860;(R)-3-Isoxazolidinone, 4-amino-;Spectrum4_000305;AIDS007654;D-amino-3-isoxazolidinone;R-(+)-Cycloserine;(R)-4-Amino-3-isoxazolidone;C3909_SIGMA;ST075697;alpha-Cycloserine;PA-94;C7670_SIGMA;4-27-00-05549 (Beilstein Handbook Reference);AI3-50153;Lopac-C-1159;NCGC00015213-01;Lopac-C-3909;NCGC00015213-02;Lopac-C-7005;NCGC00015213-03;NINDS_000098;Prestwick0_001089;Spectrum3_000371;KBioSS_001340;(4R)-4-aminoisoxazolidin-3-one;CHEBI:40009;KBio2_001340;KBio2_003908;KBio2_006476;KBio3_001341;KBioGR_000890;Prestwick2_001089;SC-49088;C6880_SIGMA;LMPK03000008;Spectrum5_000797;BSPBio_002121;SPBio_003029;30020_FLUKA
(4R)-4-amino-1,2-oxazolidin-3-one